All three catalyst technologies, i.e. homogeneous, heterogeneous and biocatalysts, are each supported by parallel rapid screening facilities.

Parallel rapid screening is not offered as a stand-alone service, but is always an integral part of customer projects. Parallel rapid screening is a means and not an end.

Find out more about rapid parallel screening